+++ Einfach investieren ? mit Kapitalschutz oder Teilschutz ? raiffeisenzertifikate.at ? jetzt in Zeichnung +++ -W-
25.01.2023 16:28:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MAXR, SESN, IMRA, ELVT

NEW YORK, Jan. 25, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

Maxar Technologies Inc. (NYSE: MAXR)'s sale to Advent International for $53.00 per share in cash. If you are a Maxar shareholder, click here to learn more about your legal rights and options.   

Sesen Bio, Inc. (NASDAQ: SESN)'s merger with Carisma Therapeutics Inc. Pre-merger Sesen Bio shareholders are expected to own approximately 41.7% of the combined company. If you are a Sesen Bio shareholder, click here to learn more about your rights and options.  

Imara Inc. (NASDAQ: IMRA)'s merger with Enliven Therapeutics, Inc. If you are an Imara shareholder, click here to learn more about your rights and options.

Elevate Credit, Inc. (NYSE: ELVT)'s sale to an affiliate of Park Cities Asset Management LLC for $1.87 per share. If you are an Elevate Credit shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-maxr-sesn-imra-elvt-301730323.html

SOURCE Halper Sadeh LLP

Nachrichten zu Eleven Biotherapeutics Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Eleven Biotherapeutics Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!